WASHINGTON — “Behind-the-counter” sales of certain drugs — that is, sold by pharmacists without a prescription — are being considered by the Food and Drug Administration, according to a notice published in the Federal Register yesterday. A public meeting is scheduled for Nov. 14. This type of drug sale has been mentioned by retailers — and some say it is already in place with the emergency contraceptive Plan B and the decongestant pseudoephedrine — but FDA said this week it is seeking public ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.